用阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）联合治疗急性白血病。 - Suppr

Suppr

超能文献

Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).

作者信息

Bodey G P, Rodriguez V, Hart J, Freireich E J

出版信息

Cancer Chemother Rep. 1970 Aug;54(4):255-62.

PMID:4946010

Abstract

摘要

相似文献

Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).用阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）联合治疗急性白血病。

Cancer Chemother Rep. 1970 Aug;54(4):255-62.

Preliminary evaluation of cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in acute leukemia of children.环磷酰胺（NSC - 26271）和阿糖胞苷（NSC - 63878）用于儿童急性白血病的初步评估。

Cancer Chemother Rep. 1969 Oct;53(5):299-303.

Treatment of acute leukemia with 5-azacytidine (NSC-102816).用5-氮杂胞苷（NSC-102816）治疗急性白血病。

Cancer Chemother Rep. 1973 Sep-Oct;57(3):319-23.

Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.环磷酰胺（NSC - 26271）、长春新碱（NSC - 67574）、阿糖胞苷（NSC - 63878）和泼尼松（NSC - 10023）（COAP）联合化疗用于成人急性白血病。

Cancer Chemother Rep. 1972 Aug;56(4):543-50.

Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.柔红霉素（NSC - 82151）、长春新碱（NSC - 67574）、阿糖胞苷（NSC - 63878）和泼尼松（NSC - 10023）联合治疗晚期成人急性白血病。

Cancer Chemother Rep. 1975 Jul-Aug;59(4):757-60.

Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.用阿糖胞苷和环磷酰胺治疗难治性白血病。

Cancer. 1973 Aug;32(2):294-7. doi: 10.1002/1097-0142(197308)32:2<294::aid-cncr2820320203>3.0.co;2-x.

Cytosine arabinoside therapy for acute myeloid leukaemia in adults.

N Z Med J. 1971 Sep;74(471):153-9.

Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1097-102.

Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.阿糖胞苷（NSC - 63878）和柔红霉素（NSC - 83142）治疗急性非淋巴细胞白血病。

Cancer Chemother Rep. 1973 Nov-Dec;57(4):485-8.

Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.成人急性白血病：根据临床和细胞培养标准评估联合化疗的缓解诱导情况。

Can Med Assoc J. 1975 Aug 23;113(4):289-94.

引用本文的文献

Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.司帕沙星的药代动力学及其与西沙必利和硫糖铝的相互作用。

Antimicrob Agents Chemother. 1997 Aug;41(8):1668-72. doi: 10.1128/AAC.41.8.1668.

Remission-induction regimens in acute nonlymphocytic leukemia.急性非淋巴细胞白血病的诱导缓解方案。

West J Med. 1980 Oct;133(4):279-88.

Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside.阿糖胞苷导致急性白血病患者骨髓中S期细胞蓄积。

Blut. 1974 Apr;28(4):299-300. doi: 10.1007/BF01631651.

Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.急性髓细胞白血病的治疗。柔红霉素与阿糖胞苷和6-硫鸟嘌呤联合用药的对比研究。

Calif Med. 1972 Dec;117(6):1-11.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验